Federica Guzzo

No ORCID on file · 5 papers in corpus
review 2025
Cancers ·doi:10.3390/cancers17091473

Background: Serum biomarkers such as Carcinoma Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) are widely used in the diagnosis and prognosis of gynecological malignancies. Serum biomarkers such as CA125 and HE4 represent essential…

observational 2024
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare12121190

The efficacy of hyaluronic acid instillations as therapy for patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) has been demonstrated in some clinical studies, with response rates up to 70%. The aim of the study is to invest…

other 2021
Biomedicines ·doi:10.3390/biomedicines9010055

Even though 80% of patients with High-Grade Serous Ovarian Cancer respond to standard first-line chemotherapy, a majority of them could relapse in the following five years due to a resistance to platinum. Human Epididymis protein 4 (HE4) is…

observational 2013
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2013.10.031

OBJECTIVE: Recto-vaginal endometriosis remains a surgical challenge. We propose a systematic surgical approach combining vaginal and laparoscopic steps for patients affected by deep endometriosis infiltrating the vaginal wall. STUDY DESIGN…

2007
·doi:10.1016/j.jmig.2007.08.561